Tuberculosis

In many of the 22 countries that account for more than 80% of the world’s tuberculosis (TB) cases, URC implements evidence-based solutions to help health systems diagnose, treat, and prevent all forms of TB, including drug-resistant and multidrug-resistant strains, and uses rapid quality-improvement cycles and continuous monitoring and evaluation to strengthen health systems and improve the quality of care for all.

Our areas of expertise include:

  • TB prevention and control
  • Community-based care and DOTS
  • Programmatic management of multidrug-resistant TB
  • TB systems strengthening
  • Connected health solutions, eHealth and mobile money solutions
  • Laboratory strengthening
  • TB-HIV coordinated care

We partner with ministries of health, national TB control programs, national reference laboratories, academic institutions, the private sector, and community and civil society institutions to ensure our work is locally supported and sustainable. Our commitment is reflected in impressive results under programs such as the TB Prevention Project in Georgia, which is emerging as a leader in the use of new drugs for multidrug-resistant TB. In Vietnam, URC’s work has contributed to an increased treatment success rate for TB-HIV co-infected patients—from 59% to more than 90% in two provinces—partially due to improved collaboration between TB and HIV programs.

To learn more, please see our Tuberculosis Brief.

 

Children receive lap desks at South African schools with messaging related to TB prevention, treatment and care (2014)